Professor, Oncology, Indiana University School of Medicine
Oncology
Dr. Patrick J. Loehrer Sr., MD
|
|
Give Review
Patrick J. Loehrer Sr., MD works in the field of Oncology. He went to Indiana University School of Medicine. Indiana University School of Medicine is ranked 45/47 in Research/PrimaryCare. He received awards:"America's Top Doctors", "America's Top Doctors for Cancer", "Indianapolis Monthly", "Fellow (FASCO)" and "Top MD". Patrick J. Loehrer Sr., MD is a published MD. He has 54 papers published. The most current publication "A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas." He is registered with Medicare and accepts Medicare payments.
Publications
- A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas.
- Micronodular thymic Neoplasms: case series and literature review with emphasis on the spectrum of differentiation.
- Medical Education and Training: Building In-Country Capacity at All Levels.
- Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.
- Critical role of NF-κB in pancreatic Cancer.
- Development of the international thymic malignancy interest group international database: an unprecedented resource for the study of a rare group of Tumors.
- NUT midline carcinomas in the thymic region.
- Phase 1 Pharmacogenetic and Pharmacodynamic Study of Sorafenib With Concurrent Radiation Therapy and Gemcitabine in Locally Advanced Unresectable Pancreatic Cancer.
- NUT Midline Carcinoma Masquerading As a Thymic Carcinoma.
- The national Cancer institute-american society of clinical oncology Cancer trial accrual symposium: summary and recommendations.
- The prognostic value of architectural patterns in a study of 37 type AB thymomas.
- The role of histology in predicting recurrence of type A thymomas: a clinicopathologic correlation of 23 cases.
- Elevated phospholipase A2 activities in plasma samples from multiple Cancers.
- Clinical practice guidelines for Cancer care: utilization and expectations of the practicing oncologist.
- Establishment and characterization of a novel cell line derived from human thymoma AB tumor.
- Phase II Trial of Erlotinib and Docetaxel in Advanced and Refractory Hepatocellular and Biliary Cancers: Hoosier Oncology Group GI06-101.
- Phase II and gene expression Analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal ca...
- Thymic Carcinoma: Outcomes After Surgical Resection.
- The oncology pharmacy in Cancer care delivery in a resource-constrained setting in western Kenya.
- Immune-Mediated Diseases and Immunodeficiencies Associated with Thymic Epithelial Neoplasms.
- Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial.
- Standard outcome measures for thymic Malignancies.
- Chemotherapy definitions and policies for thymic Malignancies.
- Role of American Society of Clinical Oncology in Low- and Middle-Income Countries.
- Phase II Study of Carboplatin and Paclitaxel in Advanced Thymoma and Thymic Carcinoma.
- Phase II study of belinostat in patients with recurrent or refractory advanced thymic epithelial Tumors.
- A phase II, multicenter study of cetuximab monotherapy in patients with refractory, metastatic coloRectal carcinoma with absent epidermal growth factor receptor immuno...
- WHO types A and AB thymomas: not always benign.
- The role of chemotherapy in advanced thymoma.
- A Phase II Study of Gemcitabine in Combination With Radiation Therapy in Patients With Localized, Unresectable, Pancreatic Cancer: A Hoosier Oncology Group Study.
- Epidermal growth factor receptor, C-kit, and Her2/neu immunostaining in advanced or recurrent thymic epithelial Neoplasms staged according to the 2004 World Health Org...
- A phase 2 trial of glufosfamide in combination with gemcitabine in chemotherapy-naive Pancreatic adenocarcinoma.
- Postoperative radiotherapy after surgical resection of thymoma: differing roles in localized and regional Disease.
- Rituximab for the treatment of thymoma-associated and de novo myasthenia gravis: 3 cases and review.
- Clinical Cancer advances 2008: major research advances in Cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
- Clinical management of thymoma patients.
- Carboplatin for stage I seminoma and the sword of Damocles.
- Pancreaticoduodenectomy: a 20-year experience in 516 patients.
- Thymoma and thymic carcinoma: therapeutic approaches.
- Phase II trial of cetuximab in patients with refractory colorectal Cancer that expresses the epidermal growth factor receptor.
- Thymoma: current medical and surgical management.
- Assessment of quality of life in outpatients with advanced Cancer: the accuracy of clinician estimations and the relevance of spiritual well-being--a Hoosier Oncology ...
- Antitumor effects of 5-fluorouracil on human colon Cancer cell lines: antagonism by levamisole.
- Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final Analysis of an intergroup trial.
- A phase II study of 13-cis retinoic acid plus interferon alpha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893).
- Stratification by risk factors predicts survival on the active treatment arm in a randomized phase II study of interferon-gamma plus/minus interferon-alpha in advanced...
- National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002.
- Role of symptom control and palliative care absTract presentations.
- Palmar-plantar erythrodysesthesia associated with capecitabine chemotherapy: a case report.
- Genetic pathways, prevention, and treatment of sporadic colorectal Cancer.
- Contribution of environment and genetics to pancreatic Cancer susceptibility.
- Opportunistic infections in a patient with HIV and thymoma.
- A gene signature to determine metastatic behavior in thymomas.
Schools
Rush Medical College Of Rush University
Rush Presby St Lukes Hospital
Indiana University
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Indianapolis Monthly
- Fellow (FASCO)
- Top MD
Education
-
Indiana University School of Medicine -
Rush University Medical Center -
Rush Medical College
Helpful Reviews
Similar Doctors
|
Dr. Pablo M. Bedano, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. H S. Boswell Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric H. Westin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erin V. Newton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sead Beganovic, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sherif S. Farag, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fredrick C. Asirwa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert L. Ilaria, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sausan Z. Abouharb, MD
This Doctor is OpenDoctor Recommended.
|